Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer (Q36673717)
Jump to navigation
Jump to search
scientific article published on January 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer |
scientific article published on January 2004 |
Statements
Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer (English)
M Colozza
A M Mosconi
C Basurto
R Cherubini
C Bisacci
V De Angelis
L Crinò
1 January 2004
1 reference
1 reference
1 reference
1 reference
1 reference